Found 76 matching trials
A Combination Study of CAR-T Therapy in r/r B-NHL PHASE2 In registry studies of CAR-T products that have been marketed globally, pat...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) PHASE1 This is a Phase 1/2, open-label, multicenter study to determine the efficac...
Show More Status
Active Not Recruiting
Location
Local Institution - 0006
Learn More & Join Trial
A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity PHASE2 This research study is studying the combination of anakinra and axicabtagen...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy PHASE3 The purpose of this study is to compare the effectiveness between CAELYX an...
Show More Location
Multiple Locations
Learn More & Join Trial
ITIL-168 in Advanced Solid Tumors PHASE1 DELTA-2 is a phase 1 clinical trial to evaluate the safety, feasibility, an...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluate CART-BCMA in Patients With Relapsed and/or Refractory Multiple Myeloma PHASE1 This is a Phase 1, multicenter, open-label study o evaluate the safety and ...
Show More Location
Hematology Department of the First Affiliated Hospital of Zhejiang University
Learn More & Join Trial
Preoperative BOTOX® Injection for Large Ventral Hernia Repair PHASE4 This study is for adults who need open surgery to repair a very large abdom...
Show More Location
Cleveland Clinic Main Campus
Learn More & Join Trial
Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma PHASE3 This is a randomized, open label, multicenter phase III trial comparing the...
Show More Location
Moores UC San Diego Cancer Center
Learn More & Join Trial
Efficacy and Safety of Olverembatinib Plus Inotuzumab Ozogamicin as First-Line Consolidation Therapy Followed by HSCT in Ph+ ALL PHASE2 To study the minimal residual disease (MRD) clearance rate of olverembatini...
Show More Location
Multiple Locations
Learn More & Join Trial
A Clinical Study of ONCT-808 in Subjects With Relapsed or Refractory B-Cell Malignancies PHASE1 This is a Phase 1/2 study to investigate the safety and efficacy of the CAR...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial